고혈압 환자에서 혈압 및 고지혈증 조절에 의한 경동맥 내중막 두께와 좌심실 심근량의 변화
Changes in Carotid Intima-media Thickness and Left Ventricular Mass by Control of Blood Pressure and Hyperlipidemia in Hypertensive Patients
2
조회
0
다운로드
1
인용
0
참고문헌
초록
Background: Hypertensive patients often present with carotid atherosclerosis, and especially those with left ventricular hypertrophy (LVH) are known to have twice the prevalence of carotid atheroma. The aims of this study were to evaluate the changes in the severity of carotid atherosclerosis and left ventricular (LV) mass by control of blood pressure (BP) and hyperlipidemia in hypertensive patients. Methods: A total of 87 treated hypertensive patients who had been diagnosed as stage 2 hypertension on Joint National Committee 7 classification in past 1 year or LVH on electrocardiographic criteria were enrolled. Both at baseline and the end of study, repetitive measurements of carotid intima-media thickness (IMT) and LV mass indexed by body surface area were performed. Measurement of carotid IMT was conducted at bilateral sides of distal common carotid artery. Results: After the follow-up period of mean 16-months, there were significant lowering in systolic and diastolic BP, respectively (144.6 ± 19.2 to 131.3 ± 13.6 mm Hg, p < 0.001; 87.5 ± 11.3 to 79.6 ± 9.4 mm Hg, p < 0.001). Carotid IMT showed no significant change (0.75 ± 0.18 to 0.76 ± 0.18 mm, p = 0.310). Although there was significant reduction in LV mass index (107.9 ± 22.0 to 101.0 ± 18.4 g/m2, p < 0.001), it was not correlated with the changes in carotid IMT (r = 0.141, p =0.197). Conclusions: Anti-hypertensive therapy combined with statin if indicated did not show significant reduction in atherosclerotic burden of carotid artery, but it seemed to prevent further progression in hypertensive patients. Decrement in LV mass achieved by BP control was not correlated with changes in carotid IMT.
Abstract
Background: Hypertensive patients often present with carotid atherosclerosis, and especially those with left ventricular hypertrophy (LVH) are known to have twice the prevalence of carotid atheroma. The aims of this study were to evaluate the changes in the severity of carotid atherosclerosis and left ventricular (LV) mass by control of blood pressure (BP) and hyperlipidemia in hypertensive patients. Methods: A total of 87 treated hypertensive patients who had been diagnosed as stage 2 hypertension on Joint National Committee 7 classification in past 1 year or LVH on electrocardiographic criteria were enrolled. Both at baseline and the end of study, repetitive measurements of carotid intima-media thickness (IMT) and LV mass indexed by body surface area were performed. Measurement of carotid IMT was conducted at bilateral sides of distal common carotid artery. Results: After the follow-up period of mean 16-months, there were significant lowering in systolic and diastolic BP, respectively (144.6 ± 19.2 to 131.3 ± 13.6 mm Hg, p < 0.001; 87.5 ± 11.3 to 79.6 ± 9.4 mm Hg, p < 0.001). Carotid IMT showed no significant change (0.75 ± 0.18 to 0.76 ± 0.18 mm, p = 0.310). Although there was significant reduction in LV mass index (107.9 ± 22.0 to 101.0 ± 18.4 g/m2, p < 0.001), it was not correlated with the changes in carotid IMT (r = 0.141, p =0.197). Conclusions: Anti-hypertensive therapy combined with statin if indicated did not show significant reduction in atherosclerotic burden of carotid artery, but it seemed to prevent further progression in hypertensive patients. Decrement in LV mass achieved by BP control was not correlated with changes in carotid IMT.
참고문헌 (21)
- Cuspidi C, "Prevalence and severity of echocardiographic left ventricular hypertrophy in hypertensive patients in clinical practice", Blood Press, 20, pp.3~9 (2010)
- Devereux RB, "Left ventricular hypertrophy in hypertension: stimuli, patterns, and consequences", Hypertension Research, 22, pp.1~9 (1999)
- Wachtell K, "Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population: the LIFE study", Hypertension, 35, pp.6~12 (2000)
- Roman MJ, "Association of carotid atherosclerosis and left ventricular hypertrophy", Journal of the American College of Cardiology, 25, pp.83~90 (1995)
- Polak JF, "Sr. Carotid-wall intima-media thickness and cardiovascular events", The New England Journal of Medicine, 365, pp.213~221 (2011)
- Taylor AJ, "Extended-release niacin or ezetimibe and carotid intima-media thickness", The New England Journal of Medicine: Research, 361, pp.2113~2122 (2009)
- Sohn IS, "Carotid intima-media thickness and arterial stiffness in hypertensive patients with first attack of ischemic stroke", Journal of the Korean Society of Hypertension, 16, pp.14~21 (2010)
- Jun HJ, "The analysis with aortic stiffness, carotid intima-media thickness and aortic valve sclerosis according to existence and severity of coronary artery disease in hypertensive patients", Journal of the Korean Society of Hypertension, 14, pp.19~27 (2008)
- Taylor AJ, "ARBITER: Arterial biology for the investigation of the treatment effects of reducing cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness", Circulation, 106, pp.2055~2060 (2002)
- Devereux RB, "Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction study", Journal of Hypertension, 20, pp.1445~1450 (2002)
- Crouse JR 3rd, "Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial", JAMA, 297, pp.1344~1353 (2007)
- Sokolow M, "The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads", American Heart Journal, 37, pp.161~186 (1949)
- Chobanian AV, "The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report", JAMA, 289, pp.2560~2572 (2003)
- National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), "Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report", Circulation, 106, pp.3143~3421 (2002)
- Stein JH, "Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine", Journal of the American Society of Echocardiography, 21, pp.93~111 (2008)
- Lang RM, "Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology", Journal of the American Society of Echocardiography, 18, pp.1440~1463 (2005)
- Pitt B, "Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators", Circulation, 102, pp.1503~1510 (2000)
- Mochizuki S, "Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study", Lancet, 369, pp.1431~1439 (2007)
- Levy D, "Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study", The New England Journal of Medicine, 322, pp.1561~1566 (1990)
- Gottdiener JS, "Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents", Circulation, 95, pp.2007~2014 (1997)
- Schmieder RE, "Reversal of left ventricular hypertrophy in essential hypertension. A metaanalysis of randomized double-blind studies", JAMA, 275, pp.1507~1513 (1996)
